Source: FinanzNachrichten

Radius: Radius Health: Radius Pharmaceuticals Expands Abaloparatide Licensing Agreement with Theramex Granting Additional Commercialization Rights Including Mexico, Canada, South Africa, Israel, and Russia

BOSTON, MA / ACCESSWIRE / December 9, 2024 / Radius Pharmaceuticals, Inc., a wholly owned subsidiary of Radius Health, Inc. ("Radius" or the "Company"), a specialty biopharmaceutical company focuse...

Read full article »
Radius's Competitors | Radius's News | Radius's Financials
Stay up-to-date with the latest news on Radius
Est. Annual Revenue
$100-500M
Est. Employees
250-500
Kelly Martin's photo - President & CEO of Radius

President & CEO

Kelly Martin

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Radius